Lipocine (LPCN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

LPCN Lipocine

Watchlist

4.7755
+0.0555+1.18%

Trading Nov 19 12:39 ET

25.54MMarket Cap-6367P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Lipocine Announces The Publication And Discussion Of A Manuscript "Oral LPCN 1148 Improves Sarcopenia And Hepatic Encephalopathy In Male Patients With Cirrhosis: A Randomized, Placebo-controlled Phase 2 Trial" In The Journal Hepatology And Discussion...
BenzingaNov 18 08:14 ET
Express News | Lipocine Announces Publication and Discussion of Lpcn 1148 Manuscript at the Liver Meeting 2024 Editor's Cut Session
ReutersNov 18 08:00 ET
Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session
PR NewswireNov 18 08:00 ET
Lipocine Shares Are Trading Lower. The Company Reported Q3 Financial Results.
BenzingaNov 7 11:51 ET
Express News | Lipocine Shares Are Trading Lower. The Company Reported Q3 Financial Results
BenzingaNov 7 11:51 ET
Lipocine 3Q Research and Development Expenses $1.6M >LPCN
Dow JonesNov 7 08:09 ET

Comments

Stock_Drift

Nov 15 16:17

After Hours Ticks. 5:16pm 11/15🦌

$Scorpius Holdings (SCPX.US)$ $Perspective Therapeutics (CATX.US)$ $Turbo Energy (TURB.US)$ $Adverum Biotechnologies (ADVM.US)$ $NFT Ltd (MI.US)$ $Xylo Technologies (XYLO.US)$ $Lipocine (LPCN.US)$ $Massimo (MAMO.US)$ $China Jo-Jo Drugstores (CJJD.US)$ $Edesa Biotech (EDSA.US)$ $Atara Biotherapeutics (ATRA.US)$ $Eterna Therapeutics (ERNA.US)$ $DDC Enterprise (DDC.US)$
📊⚡️📊

Jaguar8

Oct 31 07:23

NEWS

$Lipocine (LPCN.US)$
Lipocine Announces Distribution and License Agreement with SPC Korea to Commercialize TLANDO® in South Korea
Lipocine Inc. (NASDAQ: LPCN) has entered into a license, development and supply agreement with SPC Korea for exclusive marketing rights of TLANDO® in South Korea. The agreement includes an upfront payment, potential regulatory and sales milestone payments, royalties on net commercial sales, and a supply price arrangement. SPC Korea will be responsible for obtaining...

Trytosaveabit

Oct 10 05:13

New 8K

$Lipocine (LPCN.US)$ Lipocine Announces Positive Oral Brexanolone Quantitative EEG Results
● Quantitative Electroencephalogram (qEEG) in healthy subjects administered single doses of oral brexanolone, a neuroactive steroid (NAS), confirmed GABAA modulation
● Rapid and durable CNS target engagement confirms effective oral delivery of bioidentical brexanolone
● Promising results support continued development of oral brexanolone for the treatment of neuropsychiatric disorders

SALT LAKE CI...

Jaguar8

Oct 8 07:04

NEWS

$Lipocine (LPCN.US)$
Lipocine Announces Supply and Distribution Agreement with Pharmalink to Commercialize TLANDO® in the Gulf Cooperation Council (GCC) Countries
Lipocine Inc. (NASDAQ: LPCN) has announced an exclusive supply and distribution agreement with Pharmalink to commercialize TLANDO®, its oral testosterone replacement therapy, in the Gulf Cooperation Council (GCC) countries. The agreement covers Saudi Arabia, Kuwait, the United Arab Emirates, Qatar, Bahrain, and Oman.
Under the term...

Trytosaveabit

Oct 8 07:01

News

$Lipocine (LPCN.US)$ Reuters just
Lipocine Announces Supply and Distribution Agreement With Pharmalink to Commercialize Tlando® in the Gulf Cooperation Council (GCC) Countries

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

LPCN Lipocine

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target